Article thumbnail

IKKβ regulates essential functions of the vascular endothelium through kinase-dependent and -independent pathways

By Noboru Ashida, Sucharita SenBanerjee, Shohta Kodama, Shi Yin Foo, Matthew Coggins, Joel A. Spencer, Parisa Zamiri, Dongxiao Shen, Ling Li, Tracey Sciuto, Ann Dvorak, Robert E. Gerszten, Charles P. Lin, Michael Karin and Anthony Rosenzweig

Abstract

Vascular endothelium provides a selective barrier between the blood and tissues, participates in wound healing and angiogenesis, and regulates tissue recruitment of inflammatory cells. Nuclear factor (NF)-κB transcription factors are pivotal regulators of survival and inflammation, and have been suggested as potential therapeutic targets in cancer and inflammatory diseases. Here we show that mice lacking IKKβ, the primary kinase mediating NF-κB activation, are smaller than littermates and born at less than the expected Mendelian frequency in association with hypotrophic and hypovascular placentae. IKKβ-deleted endothelium manifests increased vascular permeability and reduced migration. Surprisingly, we find that these defects result from loss of kinase-independent effects of IKKβ on activation of the serine-threonine kinase, Akt. Together, these data demonstrate essential roles for IKKβ in regulating endothelial permeability and migration, as well as an unanticipated connection between IKKβ and Akt signalling

Topics: Article
Publisher: Nature Publishing Group
OAI identifier: oai:pubmedcentral.nih.gov:3113230
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1996). Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.
  2. (2001). Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway.
  3. (1999). Adenoviral gene transfer of activated PI 3-kinase and Akt inhibits apoptosis of hypoxic cardiomyocytes in vitro.
  4. (2005). Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo.
  5. (2005). Akt1/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis.
  6. (2002). Endothelial IKK beta signaling is required for monocyte adhesion under laminar flow conditions.
  7. (2000). HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappaB pathway.
  8. (1997). IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF- kappaB activation.
  9. (2005). IKK-beta links inflammation to obesity-induced insulin resistance.
  10. (1998). IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex.
  11. (2001). IKKalpha controls formation of the epidermis independently of NF-kappaB.
  12. (2005). Inhibition of atherogenesis in BLT1-deficient mice reveals a role for LTB4 and BLT1 in smooth muscle cell recruitment. Circulation 112,
  13. (1999). Limb and skin abnormalities in mice lacking IKKalpha.
  14. (2005). Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB.
  15. (2006). Loss of Ikkbeta promotes migration and proliferation of mouse embryo fibroblast cells.
  16. (1999). NF-kappaB activation by tumour necrosis factor requires the Akt serine- threonine kinase.
  17. (1999). NF-kappaB is a target of AKT in antiapoptotic PDGF signalling.
  18. (2006). NF-kappaB regulation of endothelial cell function during LPS-induced toxemia and cancer.
  19. (2006). Nuclear factor-kappaB in cancer development and progression.
  20. (2004). Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes.
  21. (2006). Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin.
  22. (2002). PKC-beta controls I kappa B kinase lipid raft recruitment and activation in response to BCR signaling.
  23. (2003). Protein kinase B alpha/Akt1 regulates placental development and fetal growth.
  24. (1999). Pyrrolidine dithiocarbamate prevents I-kappaB degradation and reduces microvascular injury induced by lipopolysaccharide in multiple organs.
  25. (1997). Role of translocation in the activation and function of protein kinase
  26. (2006). Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration.
  27. (1997). The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation.
  28. (1999). The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis.
  29. (2003). The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion.